ERK5: A novel IKKα-kinase in rat hippocampal neurons

Canadian Journal of Neurological Sciences

Volumn 38, Issue 4, 2011, Pages 639-648

  Goalstone, Marc ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; I KAPPA B BETA; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 7; SMALL INTERFERING RNA; TAU PROTEIN; WORTMANNIN; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); ANDROSTANE DERIVATIVE; ANTIDIABETIC AGENT; ENZYME INHIBITOR; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; HIPPOCAMPUS; HYPERINSULINEMIA; INSULIN RESISTANCE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; CELL CULTURE; CELL NUCLEUS; CYTOLOGY; CYTOPLASM; DOWN REGULATION; DRUG EFFECT; DRUG INTERACTION; ENZYMOLOGY; GENETICS; IMMUNOPRECIPITATION; METABOLISM; NERVE CELL; TIME;

AMYLOID BETA-PEPTIDES; ANDROSTADIENES; ANIMALS; CELL NUCLEUS; CELLS, CULTURED; CYTOPLASM; DOWN-REGULATION; DRUG INTERACTIONS; ENZYME ACTIVATION; ENZYME INHIBITORS; HIPPOCAMPUS; HYPOGLYCEMIC AGENTS; IMMUNOPRECIPITATION; INSULIN; MITOGEN-ACTIVATED PROTEIN KINASE 7; MODELS, BIOLOGICAL; NEURONS; NF-KAPPA B; PEPTIDE FRAGMENTS; RATS; RNA, SMALL INTERFERING; TIME FACTORS;

EID: 80053299781     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0317167100012191     Document Type: Article

References (41)

1. Roberson ED, Mucke L. 100 years and counting: prospects for defeating Alzheimer's disease. Science. 2006;314:781-4.
2. Busche MA, Eichhoff G, Adelsberger H, et al. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Science. 2008;321:1686-9.
3. Rankin CA, Sun Q, Gamblin TC. Tau phosphorylation by GSK-3beta promotes tangle-like filament morphology. Mol Neurodegener. 2007;2:12-3.
4. den Heijer T, Vermeer SE, van Dijk EJ, et al. Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia. 2003;46:1604-10.
5. Granic I, Dolga AM, Nijholt IM, van Dijk G, Eisel UL. Inflammation and NF-kappaB in Alzheimer's disease and diabetes. J Alzheimers Dis. 2009;16:809-21.
6. Chen Y-DI and Reaven GM. Insulin resistance and atherosclerosis. Diabetes Rev. 1997;4:331-42.
7. Cusi K, Maezono K, Osman A, et al. Insulin resistance differentially affects the PI 3-kinase-and MAP kinase-mediated signaling in human muscle. J Clin Invest. 2000;105:311-20.
8. Ng SS, Tsao MS, Nicklee T, Hedley DW. Wortmannin inhibits pkb/akt phosphorylation and promotes gemcitabine antitumor activity in orthotopic human pancreatic cancer xenografts in immunodeficient mice. Clin Cancer Res. 2001;7:3269-75.
9. Leitner JW, Kline T, Carel K, Goalstone M, Draznin B. Hyperinsulinemia potentiates activation of p21Ras by growth factors. Endocrinology. 1997;138:2211-4.
10. Goalstone ML, Natarajan R, Standley PR, et al. Insulin potentiates platelet-derived growth factor action in vascular smooth muscle cells. Endocrinology. 1998;139:4067-72.
11. Goalstone ML, Leitner JW, Draznin B. Mechanism of insulin's ability to potentiate mitogenic effects of growth factors. In: LeRoiths D, editor. Advances in Molecular and Cellular Endocrinology. 1999 p. 155-73.
12. Chappell J, Golovchenko I, Wall K, et al. Potentiation of Rho-Amediated lysophophatidic acid activity by hyperinsulinemia. J Biol Chem. 2000;275:31792-7.
13. Biessels GJ Kappelle LJ. Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulininduced amyloid pathology? Biochem Soc Trans. 2005;33: 1041-4.
14. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol. 2004;61:661-6.
15. de la Monte SM, Wands JR. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. J Alzheimers Dis. 2005;7:45-61.
16. Reagan LP. Neuronal insulin signal transduction mechanisms in diabetes phenotypes. Neurobiol Aging. 2005;26 Suppl 1:56-9.
17. Aljada A, Saadeh R, Assian E, Ghanim H, Dandona P. Insulin inhibits the expression of intercellular adhesion molecule-1 by human aortic endothelial cells through stimulation of nitric oxide. J Clin Endo Metab. 2000;85:2572-5.
18. Golovchenko I, Goalstone ML, Watson P, Brownlee M, Draznin B. Hyperinsulinemia enhances transcriptional activity of NF?B induced by angiotensin II, hyperglycemia and advanced glycosylation end products in vascular smooth muscle cells. Circ Res. 2000;87:746-52.
19. Mercurio T, Manning AM. Multiple signals converging on NF?B. Curr Opin Cell Biol. 1999;11:226-32.
20. Pearson G, English JM, White MA, Cobb MH. ERK5 and ERK2 cooperate to regulate NF-kappaB and cell transformation. J Biol Chem. 2001;276:7927-31.
21. Cude K, Wang Y, Choi HJ, et al. Regulation of the G2-M cell cycle progression by the ERK5-NFkappaB signaling pathway. J Cell Biol. 2007;177:253-64.
22. Sharma G, Goalstone ML. Regulation of ERK5 by insulin and angiotensin-II in vascular smooth muscle cells. Biochem Biophys Res Commun. 2007;354:1078-83.
23. Paris D, Patel N, Quadros A, et al. Inhibition of Abeta production by NF-kappaB inhibitors. Neurosci Lett. 2007;415:11-6.
24. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesitydiabetes. Central role of tumor necrosis factor-alpha. J Clin Invest. 1994;94:1543-9.
25. Lu H, Raptis M, Black E, Stan M, Amar S, Graves DT. Influence of diabetes on the exacerbation of an inflammatory response in cardiovascular tissue. Endocrinology. 2004;145:4934-9.
26. Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell. 1996; 87:13-20.
27. Baldwin AS. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immun 1996;14:49-83.
28. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol. 1998;16:225-60.
29. Baeuerle PA, Baichwal VP. NF?B as a frequent target for immunosuppressive and anti-inflamatory molecules. Adv Immunol. 1997;65:111-37.
30. Ghoda L, Lin X, Greene WC. The 90-kDa ribosomal S6 kinase (pp90rsk) phosphorylates the N-terminal regulatory domain of IkappaBalpha and stimulates its degradation in vitro. J Biol Chem. 1997;272:21281-8.
31. Chen ZJ, Parent L, Maniatis T. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. Cell. 1996;84:853-62.
32. Hacker H, Karin M. Regulation and function of IKK and IKKrelated kinases. Sci STKE. 2006;2006:re13.
33. Hacker H, Redecke V, Blagoev B, et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature. 2006;439:204-7.
34. Dinev D, Jordan BW, Neufeld B, et al. Extracellular signal regulated kinase 5 (ERK5) is required for the differentiation of muscle cells. EMBO Rep. 2001;2:829-34.
35. English JM, Pearson G, Hockenberry T, Shivakumar L, White MA, Cobb MH. Contribution of the ERK5/MEK5 pathway to Ras/Raf signaling and growth control. J Biol Chem. 1999;274: 31588-92.
36. Cavanaugh JE. Role of extracellular signal regulated kinase 5 in neuronal survival. Eur J Biochem. 2004;271:2056-9.
37. Liu L, Cavanaugh JE, Wang Y, Sakagami H, Mao Z, Xia Z. ERK5 activation of MEF2-mediated gene expression plays a critical role in BDNF-promoted survival of developing but not mature cortical neurons. Proc Natl Acad Sci USA. 2003;100:8532-7.
38. Sharma G, Goalstone ML. Dominant negative FTase (DNFTalpha) inhibits ERK5, MEF2C and CREB activation in adipogenesis. Mol Cell Endocrinol. 2005;245:93-104.
39. Steen E, Terry BM, Rivera EJ, et al. Impaired insulin and insulinlike growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes? J Alzheimers Dis. 2005;7:63-80.
40. Taubes G. Neuroscience. Insulin insults may spur Alzheimer's disease. Science. 2003;301:40-1.
41. Hassing LB, Johansson B, Nilsson SE, et al. Diabetes mellitus is a risk factor for vascular dementia, but not for Alzheimer's disease: a population-based study of the oldest old. Int Psychogeriatr. 2002;14:239-48.